Rate My Professor Carmen Évora

Carmen María Évora García is a Full Professor (Catedrática de Universidad) in the area of Pharmacy and Pharmaceutical Technology within the Department of Chemical Engineering and Pharmaceutical Technology at the School of Pharmacy, Universidad de La Laguna. She earned her PhD from the Universidad Complutense de Madrid in 1981 through the Official PhD Program in Health Sciences, with a thesis titled 'Farmacocinética de antibióticos en diálisis peritoneal' supervised by Dr. Rafael Cadórniga Carro and Dr. M.C. Sáiz Vadillo. Appointed Full Professor in 2000, she has conducted research at the Universidad de La Laguna since 1984 and previously served as Vice-Rector for Research and Technological Development. Affiliated with the Institute of Biomedical Technologies (ITB), she leads the Drug Delivery Systems (SLF) research group, focusing on innovative pharmaceutical formulations.

Her research specializations encompass drug delivery systems, including lipid-polymeric hybrid nanoparticles, scaffolds, and implants for controlled release of therapeutics aimed at bone regeneration, osteoporosis treatment, gene therapy, wound healing, and uterine leiomyoma management. Key contributions include projects funded by the Ministry of Science, Innovation and Universities, such as preclinical development of nanoparticle-based drugs for bone regeneration (2019-2021, €181,500). Évora has authored numerous publications, among the most cited being the US Patent 'Particles incorporating surfactants for pulmonary drug delivery' (1999, 671 citations), 'The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration' (Colloids and Surfaces B: Biointerfaces, 2000, 495 citations), 'Novel nanofibrous dressings containing rhEGF and Aloe vera for wound healing applications' (International Journal of Pharmaceutics, 2017, 238 citations), 'Local controlled release of VEGF and PDGF from a combined brushite–chitosan system enhances bone regeneration' (Journal of Controlled Release, 2010, 202 citations), and recent articles like 'SFRP1-Silencing GapmeR-Loaded Lipid-Polymer Hybrid Nanoparticles for Bone Regeneration in Osteoporosis' (2024) and 'Conventional and microfluidic methods: Design and optimization of lipid-polymeric hybrid nanoparticles for gene therapy' (2024). Her work has advanced biomaterials and regenerative medicine, evidenced by over 97 publications and high citation impact in pharmaceutical sciences. She teaches courses such as Biomedical Methodologies and Preclinical Evaluation of Drugs in the Master's in Biomedicine program.